Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michal Holesta

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
The Journal of Vascular Access|April 1, 2017
Gadolinium contrast agents - are they really safe?Hana Malikova, Michal Holesta
Neuro Endocrinology Letters|November 16, 2018
Hypophysitis and other autoimmune complications related to immune checkpoints inhibitors´ treatment: Spectrum of imaging appearancesHana Malikova, Michal Holesta, Alena Fialova, et al.
Neurology India|December 4, 2018
Gadoxetate disodium, a modern hepatospecific MRI contrast agent: Indirect signs for gadolinium deposition in the brain structures with signal intensity increase after intravenous applicationMichal Holesta, Jiri Weichet, Monika Grilli Wagnerova, et al.
The American Journal of Case Reports|March 15, 2020
Durable Response to Brentuximab Vedotin-Based Chemotherapy in Refractory Hodgkin Lymphoma with Central Nervous System (CNS) InvolvementHeidi Mociková, Hana Malikova, Michal Holesta, et al.
Quantitative Imaging in Medicine and Surgery|October 5, 2020
Is limited-coverage CT perfusion helpful in treatment decision-making in patients with acute ischemic stroke?Karin Kremenova, Michal Holesta, Tomas Peisker, et al.
Quantitative Imaging in Medicine and Surgery|September 15, 2023
Early and late infarct growth rate in ischemic stroke patients after successful endovascular treatment in early time window: correlation of imaging and clinical factors with clinical outcomeHana Malikova, Karin Kremenova, Jiri Lukavsky, et al.
Diagnostics (Basel, Switzerland)|October 27, 2022
CT Brain Perfusion in the Prediction of Final Infarct Volume: A Prospective Study of Different Software Settings for Acute Ischemic Core CalculationKarin Kremenova, Jiri Lukavsky, Michal Holesta, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
The Journal of Vascular Access|April 1, 2017
Gadolinium contrast agents - are they really safe?Hana Malikova, Michal Holesta
Neuro Endocrinology Letters|November 16, 2018
Hypophysitis and other autoimmune complications related to immune checkpoints inhibitors´ treatment: Spectrum of imaging appearancesHana Malikova, Michal Holesta, Alena Fialova, et al.
Neurology India|December 4, 2018
Gadoxetate disodium, a modern hepatospecific MRI contrast agent: Indirect signs for gadolinium deposition in the brain structures with signal intensity increase after intravenous applicationMichal Holesta, Jiri Weichet, Monika Grilli Wagnerova, et al.
The American Journal of Case Reports|March 15, 2020
Durable Response to Brentuximab Vedotin-Based Chemotherapy in Refractory Hodgkin Lymphoma with Central Nervous System (CNS) InvolvementHeidi Mociková, Hana Malikova, Michal Holesta, et al.
Quantitative Imaging in Medicine and Surgery|October 5, 2020
Is limited-coverage CT perfusion helpful in treatment decision-making in patients with acute ischemic stroke?Karin Kremenova, Michal Holesta, Tomas Peisker, et al.
Quantitative Imaging in Medicine and Surgery|September 15, 2023
Early and late infarct growth rate in ischemic stroke patients after successful endovascular treatment in early time window: correlation of imaging and clinical factors with clinical outcomeHana Malikova, Karin Kremenova, Jiri Lukavsky, et al.
Diagnostics (Basel, Switzerland)|October 27, 2022
CT Brain Perfusion in the Prediction of Final Infarct Volume: A Prospective Study of Different Software Settings for Acute Ischemic Core CalculationKarin Kremenova, Jiri Lukavsky, Michal Holesta, et al.
Pageof 1